MatrixCellect® 100 DBM Crunch
Providing the next generation
of regenerative therapies.
Call us today at
(877) 887-3436
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
MatrixCellect® 100 DBM Crunch
MatrixCellect® 100 DBM Crunch is processed using CellRight Technologies® proprietary demineralization process. It has been histologically proven post-sterilization to exhibit five elements of bone formation. MatrixCellect® 100 DBM Crunch does not contain any extrinsic carriers and is entirely derived from 100% allograft bone. MatrixCellect® 100 DBM Crunch is provided in a syringe.
MatrixCellect® 100 DBM Crunch is provided with a medical device Sterility Assurance Level (SAL) 10-6. The product should be stored at room temperature (15 ̊C – 30 ̊C), and has a shelf life of two years from the date of packaging.
CellRight Technologies® employs strict quality assurance and
quality control procedures to ensure patient safety. CellRight’s medical director, a licensed physician, performs an extensive medical review of the donor’s medical/social history to determine eligibility. Only donors whose screening, serologic, and microbiologic tests meet or exceed the current standards established by the Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB) are accepted for transplantation.
MatrixCellect® 100 DBM Crunch is indicated for homologous use for the treatment of surgically created or traumatic skeletal
defects.
MatrixCellect® 100 DBM Crunch may be used in surgical
procedures including:
- Spine
- Neuro
- Orthopedics
- Trauma
- Reconstruction
- Foot & Ankle
- Dental
Features and Benefits
- Osteoinductive – each lot is assayed
- Osteoconductive contains mineralized cancellous chips
- Sterile – Sterility Assurance Level (SAL) of 10-6
- Two year shelf-life
- 100% bone – no additional carrier
- Room temperature storage and shipping
- Resists irrigation
- Available in a syringe
Call us today at
(877) 887-3436
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”